Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
doi: 10.1023/a:1018955126402
Stone, W
Compound 1 showed picomolar potency (Ki: 58 pM), excellent selectivity (2759-fold selective over PDE4), and good in vivo efficacy in the rat novel object recognition (NOR) test and has been nominated for clinical development
CJC-1295 Without DAC (Modified GRF 1-29) Modified GRF (1-29) commonly referred to in research as CJC-1295 without DAC is a synthetic analogue of endogenous GHRH, representing a further-modified form of Sermorelin (GRF 1-29) with four strategic amino acid substitutions incorporated to prevent enzymatic degradation and oxidation, while increasing binding affinity to the GHRH receptor
US$ 23.32
US$ 27.53
US$ 26.56
US$ 24.55
